Founded in 2018, Trinity Innovation Fund (TIF) is dedicated to investing on biomedical innovations. Currently we are managing two funds with different focuses. Our limited partners (LPs) include renowned biopharmaceutical companies and investment institutions. Biomedical Industry Focused Put together all essential pieces such as recent healthcare reform, rapid increase of biomedical R&D expense / investment, and the large size of talent pool in China- our strong belief is that we are facing just the beginning of blossom era for Chinese biomedical industry. Hence, TIF will seize the opportunities and strive for creating extra values along the road. Competitive Team Our investment team has stunning experience in biopharmaceutical (including management roles of R&D, BD in MNCs), finance (fund management in top investment institutions) industries and academia (professorship in top universities). Team members also possess proven track record of successful investment cases (a number of recent IPOs).